Diphtheria

Showing 26 - 50 of 195

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acellular Pertussis, Haemophilus Influenzae Type b, Tetanus Trial in Hai Phong (Infanrix-IPV+Hib™)

Completed
  • Acellular Pertussis
  • +5 more
  • Infanrix-IPV+Hib™
  • Hai Phong, Vietnam
    GSK Investigational Site
Jan 3, 2020

Tetanus, Diphtheria, Haemophilus Influenzae Type b Trial in Poland (GSK2202083A vaccine, Infanrix hexa™, Menjugate™)

Completed
  • Tetanus
  • +6 more
  • GSK2202083A vaccine
  • +4 more
  • Bydgoszcz, Poland
  • +8 more
Jan 3, 2020

Diphtheria, Hepatitis B, Acellular Pertussis Trial in Worldwide (Infanrix hexa)

Completed
  • Diphtheria
  • +6 more
  • Infanrix hexa
  • Carlton, Victoria, Australia
  • +28 more
Dec 26, 2019

Acellular Pertussis, Tetanus, Diphtheria Trial in Westmead (Boostrix™)

Completed
  • Acellular Pertussis
  • +3 more
  • Boostrix™
  • Westmead, New South Wales, Australia
    GSK Investigational Site
Dec 30, 2019

Influenza, Tetanus, Diphtheria Trial in Decatur (Modified clinical reminders)

Completed
  • Influenza
  • +4 more
  • Modified clinical reminders
  • Decatur, Georgia
    Atlanta VA Medical Center
Jan 7, 2020

Poliomyelitis, Tetanus, Acellular Pertussis Trial in Spain (Study vaccines: IH+Hib-MenC/NVC; Control: IH+Meningitec)

Completed
  • Poliomyelitis
  • +4 more
  • Study vaccines: IH+Hib-MenC/NVC; Control: IH+Meningitec
  • Alcorcon, Spain
  • +21 more
Jan 3, 2020

Tetanus, Diphtheria, Haemophilus Influenzae Type b Trial in Poland (GSK2202083A vaccine, 10-valent pneumococcal vaccine (GSK

Completed
  • Tetanus
  • +6 more
  • GSK2202083A vaccine
  • +3 more
  • Bydgoszcz, Poland
  • +8 more
Dec 31, 2019

Tetanus, Acellular Pertussis, Diphtheria Trial in United States (Boostrix®, Decavac™)

Completed
  • Tetanus
  • +3 more
  • Boostrix®
  • Decavac™
  • Tucson, Arizona
  • +23 more
Dec 31, 2019

Poliomyelitis, Tetanus, Acellular Pertussis Trial in Belgaun, Chennai, Pune (Infanrix hexa™)

Completed
  • Poliomyelitis
  • +6 more
  • Infanrix hexa™
  • Belgaun, India
  • +3 more
Dec 27, 2019

Post Market Surveillance for Infanrix™

Completed
  • Diphtheria
  • +2 more
  • GSK Biologicals' Infanrix™
  • Daegu, Korea, Republic of
    GSK Investigational Site
Dec 26, 2019

Hepatitis B, Acellular Pertussis, Tetanus Trial in Germany, Poland, Spain (Pneumococcal conjugate vaccine GSK1024850A, Prevenar,

Completed
  • Hepatitis B
  • +5 more
  • Pneumococcal conjugate vaccine GSK1024850A
  • +8 more
  • Bad Saulgau, Baden-Wuerttemberg, Germany
  • +62 more
Dec 27, 2019

Diphtheria, Tetanus, Poliomyelitis Trial in Singapore (GSK Biologicals' combined DTPa-IPV/Hib vaccine)

Completed
  • Diphtheria
  • +5 more
  • GSK Biologicals' combined DTPa-IPV/Hib vaccine
  • Singapore, Singapore
    GSK Investigational Site
Dec 26, 2019

Hepatitis B, Tetanus, Poliomyelitis Trial in Edmonton, Vancouver, Truro (Infanrix™ hexa)

Completed
  • Hepatitis B
  • +5 more
  • Infanrix™ hexa
  • Edmonton, Alberta, Canada
  • +2 more
Nov 15, 2019

Poliomyelitis, Tetanus, Acellular Pertussis Trial in Korea, Republic of (Infanrix™-IPV+Hib, Infanrix™ IPV, Hiberix™)

Completed
  • Poliomyelitis
  • +4 more
  • Infanrix™-IPV+Hib
  • +4 more
  • Daegu, Korea, Republic of
  • +10 more
Nov 15, 2019

Poliomyelitis, Diphtheria, Haemophilus Influenzae Type b Trial in United States (Infanrix hexa, Pediarix, ActHIB)

Completed
  • Poliomyelitis
  • +5 more
  • Infanrix hexa
  • +8 more
  • Tucson, Arizona
  • +42 more
Nov 15, 2019

Diphtheria, Tetanus, Pertussis Trial (SMS text reminders)

Completed
  • Diphtheria
  • +6 more
  • SMS text reminders
  • (no location specified)
Nov 23, 2019

Haemophilus Influenzae Type b, Tetanus, Hepatitis B Trial in Muntinlupa (GSK2036874A vaccine, Zilbrix™/Hib vaccine, Poliorix™)

Completed
  • Haemophilus Influenzae Type b
  • +5 more
  • GSK2036874A vaccine
  • +2 more
  • Muntinlupa, Philippines
    GSK Investigational Site
Sep 17, 2019

RefortrixTM When Administered During Pregnancy inMaternal

Completed
  • Diphtheria
  • Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)]
  • Santo Andre, São Paulo, Brazil
    GSK Investigational Site
Sep 4, 2019

Diphtheria, Tetanus, Pertussis Trial in Russian Federation (Infanrix-IPV/Hib)

Completed
  • Diphtheria
  • +4 more
  • Infanrix-IPV/Hib
  • Barnaul, Russian Federation
  • +4 more
Sep 12, 2019

Diphtheria, Tetanus, Pertussis Trial (DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV)

Unknown status
  • Diphtheria
  • +5 more
  • DTwP-HepB-Sabin IPV-Hib
  • Pentavalent vaccine and Salk IPV
  • (no location specified)
Sep 3, 2019

Diphtheria, Tetanus, Pertussis Trial in Seoul (DTP-HepB-IPV-Hib vaccine, DTP-HepB-Hib vaccine & IPV)

Completed
  • Diphtheria
  • +5 more
  • DTP-HepB-IPV-Hib vaccine
  • DTP-HepB-Hib vaccine & IPV
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Aug 27, 2019

Hepatitis B, Diphtheria, Haemophilus Influenzae Type B Infection Trial (Eupenta Inj.)

Unknown status
  • Hepatitis B
  • +4 more
  • Eupenta Inj.
  • (no location specified)
Aug 13, 2019

Acellular Pertussis, Tetanus, Poliomyelitis Trial in Worldwide (Infanrix hexa, Prevnar13)

Completed
  • Acellular Pertussis
  • +4 more
  • Carlton, Victoria, Australia
  • +29 more
Jun 26, 2019

Acellular Pertussis, Diphtheria, Tetanus Trial in United States (Fluarix®, Boostrix®)

Completed
  • Acellular Pertussis
  • +2 more
  • Fluarix®
  • Boostrix®
  • Huntsville, Alabama
  • +11 more
Jun 6, 2019

Diphtheria, Tetanus, Pertussis Trial in Hung Yen (Study subjects will be vaccinated with 3 (three) vaccine doses. The first

Completed
  • Diphtheria
  • +4 more
  • Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
  • Hung Yen, Vietnam
    Hung Yen, Kim Dong
May 1, 2019